Literature DB >> 31139995

Anti-reflux mucosectomy using a cap-assisted endoscopic mucosal resection method for refractory gastroesophageal disease: a prospective feasibility study.

In Kyung Yoo1, Weon Jin Ko2, Hak Su Kim1, Hee Kyung Kim1, Jung Hyun Kim1, Won Hee Kim1, Sung Pyo Hong1, Abdullah Özgür Yeniova3, Joo Young Cho4.   

Abstract

BACKGROUND AND AIMS: Endoscopic therapy of gastroesophageal reflux disease (GERD) overcomes the "treatment gap" for patients with refractory GERD, who are not willing to go into surgery. We propose an easy and efficient technique that is referred to as anti-reflux mucosectomy (ARMS) using cap-assisted endoscopic mucosal resection (EMR-C) which could be called ARMS-C. This study aimed to investigate the short-term outcomes of ARMS-C in GERD patients.
METHODS: From December 2016 to February 2018, we performed ARMS-C in 33 patients with pathologic reflux disease and esophageal hypersensitivity. ARMS-C involved endoscopic mucosal resection at the circumference of the esophagogastric junction (EGJ), resulting in narrowing of the hiatal opening after healing. The GERD symptoms, 24-h pH monitoring results, manometry, endoscopy, and EGJ distensibility were compared before and after the procedure.
RESULTS: Six months after ARMS-C, 63% of patients discontinued the use of pump inhibitors (PPIs), while 30% patients reduced their PPI dose. The GERD questionnaire scores significantly decreased after ARMS-C, from 11.0 to 6.0 (P < 0.001). The median DeMeester score and acid exposure time based on pH monitoring also improved after ARMS-C. Furthermore, the median flap valve grade and EGJ distensibility decreased from 3.0 to 1.0 (P < 0.001) and from 19.0 to 13.9 (P < 0.001), respectively. Two patients were treated with balloon dilation due to stricture, but no other serious adverse events were encountered.
CONCLUSION: ARMS-C may be an effective and safe treatment method for GERD in terms of short-term outcomes.

Entities:  

Keywords:  Anti-reflux mucosectomy; Cap-assisted endoscopic mucosal resection; Gastroesophageal reflux disease; Short-term outcomes

Mesh:

Year:  2019        PMID: 31139995     DOI: 10.1007/s00464-019-06859-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  19 in total

1.  The evaluation of objective measurements of gastroesophageal reflux and their contribution to patient management.

Authors:  T R DeMeester; L F Johnson
Journal:  Surg Clin North Am       Date:  1976-02       Impact factor: 2.741

Review 2.  Esophageal testing: What we have so far.

Authors:  Nicola de Bortoli; Irene Martinucci; Lorenzo Bertani; Salvatore Russo; Riccardo Franchi; Manuele Furnari; Salvatore Tolone; Giorgia Bodini; Valeria Bolognesi; Massimo Bellini; Vincenzo Savarino; Santino Marchi; Edoardo Vincenzo Savarino
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

Review 3.  What is the long term acid inhibitor treatment in gastroesophageal reflux disease? What are the potential problems related to long term acid inhibitor treatment in gastroesophageal reflux disease? How should these cases be followed?

Authors:  İbrahim Hatemi; Sinem Nihal Esatoğlu
Journal:  Turk J Gastroenterol       Date:  2017-12       Impact factor: 1.852

4.  Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP).

Authors:  Monika A Kwiatek; John E Pandolfino; Ikuo Hirano; Peter J Kahrilas
Journal:  Gastrointest Endosc       Date:  2010-06-11       Impact factor: 9.427

5.  Normal values of esophageal motility after antireflux surgery; a study using high-resolution manometry.

Authors:  P W Weijenborg; E Savarino; B F Kessing; S Roman; M Costantini; J M Oors; A J P M Smout; A J Bredenoord
Journal:  Neurogastroenterol Motil       Date:  2015-07       Impact factor: 3.598

6.  A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors.

Authors:  Susanna Naggie; Becky A Miller; Kimberly B Zuzak; Brian W Pence; Ashley J Mayo; Bradly P Nicholson; Preeta K Kutty; L Clifford McDonald; Christopher W Woods
Journal:  Am J Med       Date:  2011-03       Impact factor: 4.965

7.  The gastroesophageal flap valve: in vitro and in vivo observations.

Authors:  L D Hill; R A Kozarek; S J Kraemer; R W Aye; C D Mercer; D E Low; C E Pope
Journal:  Gastrointest Endosc       Date:  1996-11       Impact factor: 9.427

8.  Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs.

Authors:  Michael S Kim; Richard H Holloway; John Dent; David S Utley
Journal:  Gastrointest Endosc       Date:  2003-01       Impact factor: 9.427

Review 9.  Refractory gastroesophageal reflux disease.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-09-30

10.  Anti-reflux mucosectomy for gastroesophageal reflux disease in the absence of hiatus hernia: a pilot study.

Authors:  Haruhiro Inoue; Hiroaki Ito; Haruo Ikeda; Chiaki Sato; Hiroki Sato; Chainarong Phalanusitthepha; Bu'Hussain Hayee; Nikolas Eleftheriadis; Shin-Ei Kudo
Journal:  Ann Gastroenterol       Date:  2014
View more
  6 in total

Review 1.  Antireflux mucosal intervention (ARMI) procedures for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Jen-Hao Yeh; Ching-Tai Lee; Min-Hung Hsu; Chi-Wen Lin; Po-Jen Hsiao; Chien-Lin Chen; Wen-Lun Wang
Journal:  Therap Adv Gastroenterol       Date:  2022-04-29       Impact factor: 4.802

Review 2.  Anti-reflux mucosectomy for refractory gastroesophageal reflux disease: a systematic review and meta-analysis.

Authors:  Rajat Garg; Abdul Mohammed; Amandeep Singh; Mary Schleicher; Prashanthi N Thota; Tarun Rustagi; Madhusudhan R Sanaka
Journal:  Endosc Int Open       Date:  2022-06-10

Review 3.  Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors.

Authors:  Fahmi Shibli; Yoshitaka Kitayama; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

Review 4.  Endoscopic anti-reflux therapy for gastroesophageal reflux disease.

Authors:  Enrique Rodríguez de Santiago; Eduardo Albéniz; Fermin Estremera-Arevalo; Carlos Teruel Sanchez-Vegazo; Vicente Lorenzo-Zúñiga
Journal:  World J Gastroenterol       Date:  2021-10-21       Impact factor: 5.742

Review 5.  Endoscopic Management of GERD.

Authors:  David P Lee; Kenneth J Chang
Journal:  Dig Dis Sci       Date:  2022-03-08       Impact factor: 3.487

6.  Clinical efficacy of endoscopic antireflux mucosectomy vs. Stretta radiofrequency in the treatment of gastroesophageal reflux disease: a retrospective, single-center cohort study.

Authors:  Xinke Sui; Xiaopei Gao; Lu Zhang; Bin Zhang; Changqing Zhong; Yan Chen; Xiaoying Wang; Dou Li; Wei Wu; Lianyong Li
Journal:  Ann Transl Med       Date:  2022-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.